搜尋結果
LifeSphere Regulatory Affairs software delivers end-to-end regulatory information management in an all-new, fully unified cloud platform that accelerates speed to market, enhances data quality and streamlines collaboration across teams.
Our world-class leadership team has decades of experience with emerging and established technology, SaaS, and life science organizations. These trusted executives are adept at guiding companies through rapid expansion and now apply those winning strategies to power ArisGlobal’s next phase of growth.
China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software.
Key Use Cases of Automation in Pharmacovigilance. ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market.
- How The Digital Revolution Has Impacted Medical Affairs
- How The Automation Has Changed Medical Affairs Expectations
- How Artificial Intelligence Is Likely to Further Change Medical Affairs
In this digital age, Medical Affairs has increasingly become a key strategic investment for global life sciences firms. New, specialized medicines require more scientific and evidence-based information for HCPs. Digital advancements are also contributing to the importance of Medical Affairs and shifting the entire healthcare landscape. Technology h...
Medical Affairs is seeing a notable transformation thanks in part to its emphasis on automation. With its new role as a business driver, it is evolving from a part of pharma that provides support to one that plays a much more strategic role. Offering medical insights to detect strategic opportunities or risks for the company is one example of how M...
The current approach of Medical Information is both manual and rigorous. Artificial intelligence is also playing its part in simplifying things for the future of medical affairs. The Covid-19 pandemic has presented us with challenges on all fronts and the demand for products to go to market faster means a mounting workload on medical affairs teams....
2018年11月27日 · MIAMI, FL. November 27, 2018 – The U.S. Food and Drug Administration (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS).
Today’s pharmacovigilance department faces some of the most vexing issues facing life sciences companies. This white paper shares how cognitive computing has the potential to revamp the practice of pharmacovigilance, from a tedious, resource-intensive process to a dynamic and efficient practice.
伍怡君fb 相關
廣告過去一個月已有 超過 1 萬 位使用者造訪過 mjspicy.onelink.me
競技麻將2大獎送不停！精緻畫面、音效逼真，介面輕鬆一指打牌，還有拉霸機、捕魚機遊戲任你玩！ 打麻將，沒牌咖！「競技麻將2」一秒湊桌、隨開即玩，創角就送8千萬，升階段位賽，讓你萌新變傳奇
